Investment Fund

Purchase Restrictions: Shares of Capital Group Central Corporate Bond Fund (“fund”) are not offered to the public. Investments in the fund may be made only by certain institutional investors, including investment companies and certain other investment vehicles and accounts managed by the fund’s investment adviser and its affiliates. Shares of the fund are restricted securities and cannot be transferred or resold without registration under the Securities Act of 1933, as amended (“1933 Act”), or an available exemption from registration under the 1933 Act.
783 Total Holdings:
As of 6/30/25
All Holdings: 1 - 15 of 783
Security Name Asset Type Shares or
Principal Amount
Market Value Percent of
Net Assets
descending arrow
Capital Group Central Cash Fund Short Term 7,084,876 $708,487,568.00 6.7%
U.S. Treasury 3.875% 6/30/2030 Fixed Income 322,555,000 $323,802,481.00 3.06%
U.S. Treasury 4.25% 5/15/2035 Fixed Income 172,411,000 $172,640,289.00 1.63%
New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 Fixed Income 85,198,000 $80,281,735.00 0.76%
Chubb INA Holdings, LLC 5.00% 3/15/2034 Fixed Income 77,669,000 $79,169,876.00 0.75%
Bristol-Myers Squibb Co. 5.20% 2/22/2034 Fixed Income 76,118,000 $77,986,925.00 0.74%
U.S. Treasury 5% 5/15/2045 Fixed Income 76,363,000 $78,433,315.00 0.74%
Pacific Gas and Electric Co. 2.50% 2/1/2031 Fixed Income 86,139,000 $74,818,354.00 0.71%
Cisco Systems, Inc. 5.05% 2/26/2034 Fixed Income 69,323,000 $70,985,712.00 0.67%
Takeda U.S. Financing, Inc. 5.20% 7/7/2035 Fixed Income 69,251,000 $69,286,457.00 0.65%
AbbVie, Inc. 5.05% 3/15/2034 Fixed Income 66,997,000 $68,239,258.00 0.64%
Synopsys, Inc. 5.15% 4/1/2035 Fixed Income 66,979,000 $67,538,208.00 0.64%
U.S. Treasury 3.875% 6/15/2028 Fixed Income 66,823,000 $67,175,358.00 0.63%
Oracle Corp. 5.50% 8/3/2035 Fixed Income 64,456,000 $65,912,963.00 0.62%
Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 Fixed Income 65,138,000 $61,539,386.00 0.58%
All Holdings: 1 - 15 of 783